| Identification | |
| Name: | 5-Heptenoic acid,7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-,(5Z)- |
| Synonyms: | 5-Heptenoicacid, 7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-,(5Z)- (9CI); 5-Heptenoic acid,7-[2-[4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-,[1R-[1a(Z),2b(1E,3R*),3a,5a]]-; (+)-Cloprostenol;16-(m-Chlorophenoxy)-17,18,19,20-tetranorprostaglandin F2a; Dalmaprost D; Dalmazin;Prolise; d-Cloprostenol |
| CAS: | 54276-21-0 |
| Molecular Formula: | C22H29 Cl O6 |
| Molecular Weight: | 424.92 |
| Molecular Structure: | ![(C22H29ClO6) 5-Heptenoicacid, 7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxyc...](https://img1.guidechem.com/chem/e/dict/13/54276-21-0.jpg) |
| Properties | |
| Density: | 1.321g/cm3 |
| Specification: |
?(+)-Cloprostenol (CAS NO.54276-21-0) is also named as?5-Heptenoic acid,7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-,(5Z)- ;?5-Heptenoicacid, 7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-,(5Z)- (9CI) ; 5-Heptenoic acid,7-[2-[4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-,[1R-[1a(Z),2b(1E,3R*),3a,5a]]- ;?16-(M-Chlorophenoxy)-17,18,19,20-tetranorprostaglandin F2a ; Dalmaprost D ; Dalmazin;Prolise ; d-Cloprostenol ;?(5Z)-7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-Chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoic acid . |
| Safety Data | |
 |
|
